Decreased isavuconazole trough concentrations in the treatment of invasive aspergillosis in an adult patient receiving extracorporeal membrane oxygenation support

Lessons from isavuconazole therapeutic drug monitoring at a United Kingdom Reference Center

(2020) Andrew M Borman et al.   MEDICAL MYCOLOGY

Oxygenator impact on voriconazole in extracorporeal membrane oxygenation circuits

(2020) Jeffrey J Cies et al.   PERFUSION-UK

Isavuconazole Treatment in a Mixed Patient Cohort with Invasive Fungal Infections: Outcome, Tolerability and Clinical Implications of Isavuconazole Plasma Concentrations

(2020) Christoph Zurl et al.   Journal of Fungi

Serial monitoring of isavuconazole blood levels during prolonged antifungal therapy

(2019) E Furfaro et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Altered Pharmacokinetics and Dosing of Liposomal Amphotericin B and Isavuconazole during Extracorporeal Membrane Oxygenation

(2019) Yanjun Zhao et al.   PHARMACOTHERAPY

Isavuconazole Concentration in Real-World Practice: Consistency with Results from Clinical Trials

(2018) David Andes et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Optimising drug dosing in patients receiving extracorporeal membrane oxygenation

(2018) Vesa Cheng et al.   Journal of Thoracic Disease

Population Pharmacokinetics of Isavuconazole from Phase 1 and Phase 3 (SECURE) Trials in Adults and Target Attainment in Patients with Invasive Infections Due to Aspergillus and Other Filamentous Fungi

(2016) Amit Desai et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Pharmacokinetic changes in patients receiving extracorporeal membrane oxygenation

(2012) Kiran Shekar et al.   JOURNAL OF CRITICAL CARE

Pharmacokinetics of caspofungin and voriconazole in critically ill patients during extracorporeal membrane oxygenation

(2009) I. Spriet et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY